Skip to content

Medifast MED Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin70.1%-1.2pp71.3%-1.1pp72.4%-1.4pp73.8%0.0pp73.9%+0.1pp
Operating margin-4.7%-1.0pp-3.7%-2.4pp-1.3%-1.4pp0.1%+1.3pp-1.2%-1.6pp
Net margin-5.8%-0.9pp-4.8%-4.9pp0.1%-0.7pp0.8%+2.0pp-1.3%-1.6pp
Returns
Return on equity-9.8%-0.7pp-9.1%-9.2pp0.1%-1.6pp1.7%+5.0pp-3.3%-4.3pp
Return on invested capital-11.8%-0.6pp-11.1%-8.7pp-2.4%-2.6pp0.2%+5.0pp-4.7%-5.9pp
Efficiency
Asset turnover1.3×-0.1×1.4×-0.1×1.5×-0.2×1.7×-0.2×1.9×-0.2×
Liquidity
Current ratio4.8×+0.1×4.7×+0.2×4.4×0.0×4.5×+0.9×3.5×+0.2×
Leverage
Debt-to-equity0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×
Per Share
Book value per share$17.96-0.8%$18.11-7.3%$19.530.0%$19.53+1.4%$19.27+0.5%
Valuation
Market capitalization$121.87M-17.4%$117.39M-21.9%$150.25M-0.2%$150.58M+2.1%$147.44M-23.5%
Price / sales0.4×0.0×0.3×0.0×0.3×0.0×0.3×0.0×0.3×0.0×
Price / book0.6×-0.1×0.6×-0.1×0.7×0.0×0.7×0.0×0.7×-0.2×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Medifast's profit margins?
Medifast (MED) runs a 70.1% gross margin and a -4.7% operating margin, with a -5.8% net margin.
Where do Medifast's ratios come from?
Every ratio is computed from Medifast's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.